CDMO Outlook: Headwinds Loom for the Industry
By

By
After a robust 2021, the CDMO industry entered 2022 with a lot of momentum, but at the close of 1Q 2022, market conditions are more uncertain. Highlights from a DCAT Week 2022 presentation.

Incorporating Sustainability into the Bio/Pharma Supply Chain: Where Does the Industry Stand?
By

By
A newly released DCAT benchmarking study examines the targets and progress made by bio/pharma companies and suppliers in reaching their sustainability goals.